Goldman Sachs Group Inc Lexicon Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 401,291 shares of LXRX stock, worth $393,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

401,291

Previous 373,431 7.46%

Holding current value

$393,265

Previous $627,000 0.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $42,068 - $66,585	27,860 Added 7.46%	401,291 $630,000
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $334,514 - $495,254	217,217 Added 139.05%	373,431 $627,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $102,862 - $283,267	-79,125 Reduced 33.62%	156,214 $374,000
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.53 $124,372 - $190,289	-124,372 Reduced 34.58%	235,339 $360,000
Q3 2023 May 14, 2024	BUY	$1.06 - $2.33 $131,834 - $289,786	124,372 Added 52.85%	359,711 $392,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $204,894 - $450,382	-193,297 Reduced 34.95%	359,711 $392,000
Q2 2023 May 14, 2024	BUY	$2.15 - $3.49 $567,750 - $921,604	264,070 Added 91.39%	553,008 $1.27 Million
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $567,750 - $921,604	264,070 Added 91.39%	553,008 $1.27 Million
Q1 2023 May 14, 2024	BUY	$1.99 - $2.68 $44,936 - $60,517	22,581 Added 8.48%	288,938 $702,000
Q1 2023 May 11, 2023	BUY	$1.99 - $2.68 $44,936 - $60,517	22,581 Added 8.48%	288,938 $702,000
Q4 2022 May 14, 2024	BUY	$1.8 - $2.56 $45,784 - $65,116	25,436 Added 10.56%	266,357 $508,000
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $45,784 - $65,116	25,436 Added 10.56%	266,357 $508,000
Q3 2022 May 14, 2024	BUY	$1.94 - $3.43 $63,818 - $112,833	32,896 Added 15.81%	240,921 $578,000
Q3 2022 Nov 10, 2022	BUY	$1.94 - $3.43 $63,818 - $112,833	32,896 Added 15.81%	240,921 $578,000
Q2 2022 May 14, 2024	SELL	$1.31 - $2.69 $35,781 - $73,474	-27,314 Reduced 11.61%	208,025 $387,000
Q2 2022 Aug 15, 2022	BUY	$1.31 - $2.69 $33,213 - $68,202	25,354 Added 13.88%	208,025 $387,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $49,118 - $97,985	25,189 Added 15.99%	182,671 $381,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $257,437 - $416,225	67,569 Added 75.15%	157,482 $621,000
Q3 2021 Nov 10, 2021	BUY	$3.38 - $5.35 $303,905 - $481,034	89,913 New	89,913 $432,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $185M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Lexicon Pharmaceuticals, Inc. Transaction History